s e19Results: A total of 205 patients were included, 117 (57.1%) were males, of whom 40 (19.5%) died and 165 (80.5%) were discharged. The mean value of the patients' age was 53.7±13.8 years old, and the median hospitalization-day was 11 (range: 1-45) days. Hypertension was the most common comorbidity (n=72;35.1% patients); 13 (18.1%) were dead and 59 (81.9%) survived. A chi-square test showed no statistically signifi cant difference between mortality and hypertension, X 2 (1, N=205) =0.15, p=0.70; OR: 0.87, 95% confi dence interval (CI) 0.42-1.80. Logistic regression analysis reveals that patient's age is the only statistically signifi cant factor for death in this study (P <0.05; OR: 1.05, 95% CI 1.02-1.08). Conclusion:Hypertension is not associated with mortality in COVID-19 patients. Further investigations including larger sample size and more possible variables are warranted to understand this relationship further.